Showing results (21-30 of 34) with videos related to
Sort By:
Pageof 4
The Journal of Biological Chemistry|October 17, 2024
PP2A activation overcomes leptomeningeal dissemination in group 3 medulloblastomaNazia Nazam, Michael H Erwin, Janet R Julson, et al.Cell Death & Disease|January 15, 2026
PP2A activation targets MYCN in neuroblastomaNazia Nazam, Shamza Manzoor, Maryam Shaikh, et al.Journal of Pediatric Surgery|March 12, 2023
The Effects of Protein Phosphatase 2A Activation with Novel Tricyclic Sulfonamides on HepatoblastomaLaura V Bownes, Janet R Julson, Colin H Quinn, et al.Scientific Reports|September 15, 2019
Focal Adhesion Kinase Inhibition Contributes to Tumor Cell Survival and Motility in Neuroblastoma Patient-Derived XenograftsLaura L Stafman, Adele P Williams, Raoud Marayati, et al.Cancers|November 27, 2024
Novel PP2A-Activating Compounds in NeuroblastomaNazia Nazam, Laura V Bownes, Janet R Julson, et al.Journal of Pediatric Surgery|March 18, 2022
Metastatic human hepatoblastoma cells exhibit enhanced tumorigenicity, invasiveness and a stem cell-like phenotypeRaoud Marayati, Janet R Julson, Laura V Bownes, et al.Translational Oncology|April 22, 2021
Downregulation of PDGFRß Signaling Overcomes Crizotinib Resistance in a TYRO3 and ALK Mutated Neuroendocrine-Like TumorColin H Quinn, Andee M Beierle, Adele P Williams, et al.Translational Oncology|July 3, 2024
Preclinical evidence for employing MEK inhibition in NRAS mutated pediatric gastroenteropancreatic neuroendocrine-like tumorsColin H Quinn, Andee M Beierle, Adele P Williams, et al.Translational Oncology|July 31, 2019
UAB30, A Novel Rexinoid Agonist, Decreases Stemness In Group 3 Medulloblastoma Human Cell Line XenograftsAdele P Williams, Evan F Garner, Laura L Stafman, et al.Clinical & Experimental Metastasis|October 31, 2022
PIM3 kinase promotes tumor metastasis in hepatoblastoma by upregulating cell surface expression of chemokine receptor cxcr4Raoud Marayati, Janet Julson, Laura V Bownes, et al.Pageof 4